Company:  PDI INC (PDII)
Form Type:  10-Q
Filing Date:  8/5/2013 
CIK:  0001054102 
Address:  MORRIS CORPORATE CENTER 1, BUILDING A
300 INTERPACE PARKWAY
 
City, State, Zip:  PARSIPPANY, New Jersey 07054 
Telephone:  (862) 207-7800 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.39  
Change: 
-0.01 (-0.19%)  
Trade Time: 
02:06 PM EST  
Market Cap: 
$82.62M
Description of Business
We are a leading provider of outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States. We are a leading provider of outsourced sales teams that target healthcare providers, offering a range of complementary sales support services designed to achieve our customers� strategic and financial product objectives. In addition to outsourced sales teams, we also provide other promotional services including clinical educator services, digital communications, teledetailing and through our Interpace BioPharma business unit, we provide pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. Combined, our services offer customers a range of both personal and non-personal promotional options for the commercialization of their products throughout their lifecycles, from development through maturity.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I
      FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
          INCOME STATEMENT
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        INCOME STATEMENT
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 5. Other Information
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO SECTION 302
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO SECTION 302
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS